Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Prestige Consumer Healthcare (PBH) Stock Price & Analysis
103 Followers
PBH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$56.34 - $75.31
Previous Close$71.24
Volume214.14K
Average Volume (3M)253.93K
Market Cap
$3.54B
Enterprise Value$4.69B
Total Cash (Recent Filing)$63.62M
Total Debt (Recent Filing)$1.21B
Price to Earnings (P/E)17.1
Beta0.48
Next Earnings
Aug 08, 2024EPS Estimate
$0.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.17
Shares Outstanding49,915,366
10 Day Avg. Volume285,348
30 Day Avg. Volume253,934
Standard Deviation0.07
R-Squared0.14
Alpha0.00969
Financial Highlights & Ratios
Price to Book (P/B)-2.76
Price to Sales (P/S)3.07
Price to Cash Flow (P/CF)12.10
P/FCF Ratio11.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.13
Enterprise Value/Gross Profit7.50
Enterprise Value/Ebitda15.02
Forecast
1Y Price Target
$82.67Price Target Upside16.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Prestige Consumer Healthcare News
Bulls Say, Bears Say
Bulls Say
Financial PerformancePBH's execution, consistency, and predictability of financial performance has been excellent in recent years.
Market PositionPBH is a high-quality company with #1 or #2 brands in most of their categories, no cyclicality, and a 35% EBITDA margin.
Share Repurchase ProgramPBH just announced a $300M share repurchase program and indicated it was just 30% of the expected $1B in cash expected to be generated over the next 4 years, leaving plenty of allocation flexibility to M&A and brand investment.
Bears Say
Earnings Miss4Q EPS misses on supply chain disruption, expect issues to be resolved by 2H, thesis remains intact.
Sales ImpactSales in 1H are still expected to be impacted by supply chain challenges from two eye-care suppliers as they both ramp up to speed.
Supply Chain DisruptionPBH experienced significant disruptions in supply of Clear Eyes due to business interruptions from suppliers.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $56.34 and its highest was $75.31 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Currently, no data Available
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Aug 08, 2024 which is in 17 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on May 14, 2024. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.139 by -$0.119.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare does not currently pay dividends.
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is $0.86.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,675,034 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.02 in its last earnings report, missing expectations of $1.139. Following the earnings report the stock price went down -7.01%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Among the largest hedge funds holding Prestige Consumer Healthcare’s share is Ariel Investments LLC. It holds Prestige Consumer Healthcare’s shares valued at 186M.
---
Prestige Consumer Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$82.67 (16.04% Upside)
$82.67 (16.04% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 40.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.67%
12-Months-Change
Fundamentals
Return on Equity
13.50%
Trailing 12-Months
Asset Growth
-1.11%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
---
PBH Company Deck
---
PBH Earnings Call
Q4 2024
0:00 / 0:00
---
PBH Stock 12 Month Forecast
Average Price Target
$82.67
▲(16.04% Upside)
Technical Analysis
Best Analysts Covering PBH
1 Year
1 Year Success Rate
6/15 ratings generated profit
1 Year Average Return
-6.41%
upgraded a buy rating last month
Copying Linda Bolton Weiser's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -6.41% per trade.
---